Day One Biopharmaceuticals

DAWN

21.5300.00% ( 0.000 )

Delisted: Apr 27, 16:00:00 (EDT)

Q4 FY2025 Earnings

Financial report interval: 2025.10.01 - 2025.12.31

Overview: Day One Biopharmaceuticals(DAWN) the Revenue is 53.72 M (+83.92%);the EBIT is -27.46 M (+57.97%);the EPS is -0.21 (+67.22%).

Actual

YoY

Estimate

YoY

Vs estimate

YoY

Revenue

0.05B83.92%

----

----

EBIT

-0.03B57.97%

----

----

EPS

-0.210367.22%

----

----

Revenue

ActualEstimateUnit: USD

Quarterly

EBIT

ActualEstimateUnit: USD

Quarterly

Net income

ActualEstimateUnit: USD

Quarterly

EPS

ActualEstimateUnit: USD

Quarterly